Case-Crossover Design To Study ED Drug AEs Advised By Pfizer Consultant
Case-crossover study design may be appropriate to study adverse events for medications taken on an as needed basis, such as erectile dysfunction drugs, Pfizer consultant Murray Mittleman, MD, Beth Israel Deaconess Medical Center, told Center for Drug Evaluation & Research staff at a May 31 seminar.
You may also be interested in...
Pfizer has updated labeling for Viagra (sildenafil) to include postmarketing reports of adverse events and discussion of the effect of sexual activity with Viagra on cardiovascular safety.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials